Published by
@ShahidNShah
@ShahidNShah
Cementing its position as the world's leading forum for liquid biopsy specialists, the 9th Liquid Biopsy for Precision Oncology Summit returns to San Diego in 18 - 20 February - with a refreshed agenda providing crucial insights spanning biomarker discovery to commercialization, and each critical step in between.Over the past 12 months, liquid biopsy testing has continued to revolutionize diagnostics and personalized medicine; from the integration of AI and automation to elevate liquid biopsy capabilities, to the approval of MRD as an endpoint in Multiple Myeloma.Whether you're new to the field or a seasoned expert, join over 250 of the industry's top decision-makers from AstraZeneca, Amgen, Eli Lilly, AbbVie, BLOODPAC, Boundless Bio, and more. [Read on lbx-summit.com](https://lbx-summit.com/take-part/register/)
Continue reading at lbx-summit.com
February 19 to February 20, 2025
Cambridge,USA
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 4, 2024 at 5:17am